EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. It will also feature most recent advances in new technologies.
The Novartis Institute of Biomedical Research (NIBR) in Basel cordially invites students, post-docs and participants from academia participating in the EFMC-ISMC 2021 symposium to an interactive discovery chemistry event on the Novartis campus.
In a series of dedicated sessions, the interface between chemical biology and drug discovery will be highlighted, including topics such the use of chemical probes for target discovery, molecular imaging, and photochemical approaches. In response to frequent requests by attendees of previous conferences, two sessions will be dedicated to advances in synthetic methodology for drug discovery. Finally, particular emphasis will again be put on first time disclosures and recent highlights in medicinal chemistry.